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Abstract 
 
Non photochemical quenching (NPQ) is an important way for plants to protect 
themselves from photooxidative damage. In higher plants, the major and most rapid 
part of NPQ is qE, which is controlled by the Violaxanthin de-epoxidase (VDE) and 
zeaxanthin epoxidase (ZE). VDE converts Violaxanthin (Vx) to Antheraxanthin (Ax), 
and then to Zeaxanthin (Zx). Several experiments were carried through to analyze 
functional and structural properties of VDE. All the 13 Cysteines (Cys) in VDE were 
mutated to Serine (Ser) to detect the Cys that contribute to VDE activity. 12 
mutations were found with decreased VDE activity. The function of the region 
between the N-terminal domain and the lipocalin domain was investigated by 
expression of the peptide before and after the linker region in different lengths 
combination and followed activity measurement. The results showed that the two 
independent domains lost majority of activity and N-terminal part of linker region 
was more important for activity. An experiment was set up to analyze the function of 
C-terminal by measuring the activity of VDE after cleaving different length of 
C-terminal. The result showed different degrees of activity loss that was caused by 
removal of different lengths of the C-terminal. A number of experiments suggests 
that VDE acts as a dimer that is formed at low pH. These experiments will contribute 
to further research of the function and structure of VDE.  
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Introduction 
 
Photosynthesis is one of the most important biochemical processes in nature; the 
energy generated from this process has supported the majority of consumption of 
the living creature on this planet. The absorption of light energy by antenna 
pigments and the transmission of excited energy to reaction center photosystem I 
(PSI) and photosystem II (PSII) are the primary steps of photosynthesis. Like the 
raining /drought season changing in African savannah, like a several seconds shade 
created by a passing cloud in a sunny summer afternoon, the light quantity in natural 
environment never stop changing in a time scale ranges from seconds to seasons. 
Light is a very important environmental parameter, which to the fact that numerous 
of biochemical and developmental response to light have evolved in plants to help 
photosynthesis and growth optimization (K.K Niyogi, 2001). In their natural 
environment, most plants usually receive more sunlight than they actually consume 
for photosynthesis. Since most of plants are immobilized, it is necessary for plants to 
balance the absorption and utilization of light energy, and further, to minimizing the 
potential of photooxidative damage caused by additional absorbed light. To achieve 
this goal, some plants can adjust the light absorption through leaf and chloroplast 
movements, or even regulate the light harvesting antennae size in gene expression 
level (K.K Niyogi, 2001); beside such adjustment, plants also have ways to get rid of 
the redundant light energy which have been captured; one of those ways is so called 
non-photochemical quenching (NPQ) which can quench singlet-excited chlorophylls 
(Chl) and dissipate the excess excitation energy as heat (see Figure 1).  
 
Figure 1. Various way of deexcitation of excited Chl. When 1Chl* is formed by Chl 
absorbed light, in order to go back to ground state, it can either produce 3Chl* and 
then produce 1O2*, a very reactive oxygen species; or release the energy into light 
(seen as fluorescence), provide energy to photosynthetic reaction, or dissipate into 
heat(NPQ). 
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Previous research showed according to different relaxation kinetics in darkness and 
response to different inhibitors, NPQ can at least be divided into three parts: the 
major and most rapid component, qE; a second component, qT; and the third 
component, qI (Horton and Hague, 1988). The previous research also showed that 
the activation of qE requires a low lumen pH which can be generated by 
photosynthetic electron transport (Gilmore and Yamamoto, 1992). From previous 
results, a xanthophyll cycle was found in all organisms that has qE. Today, two 
different xanthophyll cycle has been discovered. Violaxanthin cycle exists in plants, 
green algae and brown algae; it is a pH dependent conversion cycle, from 
violaxanthin (Vx) to antheraxanthin (Ax), and then to zeaxanthin (Zx) at low pH and 
convert back from Zx to Vx at high pH. Diadinoxanthin cycle exists in diatoms and 
other eukaryotic algae; the conversion process in this cycle is between 
diadinoxanthin and diatoxanthin (Yamamoto et al. 1962).  
 
The violaxanthin cycle is catalyzed by two enzyme, violaxanthin de-epoxidase (VDE) 
and zeaxanthin epoxidase (ZE) (see figure 2). ZE catalyze the epoxidation reaction 
that converts zeaxanthin to violaxanthin. VDE is a 43-kDa nucleus-encoded protein 
and located in lumen. It converts from violaxanthin via antheraxanthin, finally to 
zeaxanthin (Bugos and Yamamoto, 1996). Previous research illustrated that VDE can 
associate with the thylakoid membrane when lumen has been acidified (Hager and 
Holocher, 1994), in thylakoid membrane, VDE can interact with its substrate 
violaxanthin. Bratt et al (1995) also showed that VDE use ascorbic acid to reduce the 
epoxide group of violaxanthin.  
 
 
Figure 2. Overview of violaxanthin cycle. In lumen, at low pH (pH 5.2), VDE converts 
violaxanthin to Zeaxanthin, the reaction requires ascorbate acid as reductant; while 
in stroma, at pH 7.0, ZE converts zeaxanthin back to violaxanthin.  
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Researches of our group were mainly focused on VDE from spinach. The previous 
experimental work has successfully cloned spinach VDE sequence (without signal 
peptide) into the Escherichia coli (E. coli) Top10 strain, the expression product (VDE3) 
had 1 amino acid (Methionine,Met) extra in N-terminal compared to normal spinach 
VDE. From bioinformatics analysis result, VDE3 can be separated into three parts 
(Figure 3). The Cys-rich N-terminal domain which contains 11 Cysteines only exists in 
VDE family and has no homologous sequence in other known protein families. The 
previous research had illustrated that the Glu-rich C-terminal might be protonated in 
low pH environment and contributed to thylakoid membrane binding process (Bugos 
and Yamamoto, 1996). A lipocalin domain is between the previous two domains. 
Arnoux et al (2009) have considered such domain as a substrate binding region, their 
group also crystalized a non-active structure of lipocalin domain.  
 
Figure 3. The VDE3 sequence. White: extra Met. Red region: N-terminal domain. 
Green region: suspected linker region. Dark green region: lipocalin domain. Cyan 
region: C-terminal domain. Amino acid marked in yellow: Cysteine. 
 
Between N-terminal domain and lipocalin domain (Figure 3), a 19 amino acids region 
shows less conservation among VDE family. The bioinformatics analysis showed such 
region might be a random coil part and shows less conserved among VDE. The 
function of this peptide still remains unknown, and we suggested such peptide may 
work as a linker region that connects the two domains and has no contribution to 
VDE activity. A series of experiment had set up by our group to investigate the 
function of this linker region. Firstly, three points on this peptide were determined as 
cleavage sites; corresponding to each cleavage site, two peptides were cloned and 
expressed separately, and the expression products corresponding to every cleavage 
point were mixed together and applied to activity measurement. The result of 
activity assay provided evidence of ability of independent accurate refolding of the 
two domains beyond linker region. On the other hand, a Tobacco Etch Virus (TEV) 
protease cleavage site was fused to the linker region by using two-step PCR, the 
fusion protein was expressed and applied to activity measurement, after assured it 
was active, the fusion protein was cleaved into two part by using TEV Protease, the 
two independent active domains were acquired. The results from our experiments 
showed it might remain a little activity in some peptide combination, but in general, 
the two domains without linker part were almost impossible to form active structure 
independently; the low active TEV-site fusion VDE and the non-active peptide 
combination also showed part of the linker region was important for VDE3 activity. 
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In 1981, R.B. Silverman discovered that vitamin K epoxide reductase use cysteine as 
active site to process epoxidation activity. Previous researches have not identified the 
active site. There are 13 cysteines (Cys) in VDE, 11 Cys in N-terminal region and 2 in 
lipocalin domain; hence it is meaningful to investigate if any cysteine works as active 
cite which means the removal of such Cys will give absolute non-active mutant. To 
test the function of Cys, all Cys has been mutated to serine (Ser) one by one by our 
group using 2-step PCR method. By measuring the activity change of all mutants, Cys 
which contributes to VDE function has been determined. The activity measurement 
results from our experiments showed that all Cys except the first one (position Cys08) 
are necessary for the activity. Mutation of those 12 Cys will dramatically decrease the 
activity, but whether the cysteines influence the VDE activity in structural or 
functional way is still unknown. 
 
According to research from H.Y. Yamamoto et al (2001), deletion of part of C-terminal 
of VDE will not influence activity. Three different peptide lengths have been 
examined by our group to find how far distance can be deleted from C-terminal end 
and give no influence on VDE activity. By measuring activity of the three expression 
products, the shortest active VDE peptide can be identified. Our experiment result 
showed that the removal of last 71 amino acids of VDE will keep 20% VDE3 activity, 
and further more cleavage decrease the activity rapidly. 
 
The lipocalin domain structure obtained by Arnoux’s group (Arnoux et al, 2009) 
showed at low pH, the domain exists in dimer-form, a peak shift was witnessed by us 
in diagram from Gel-filtration chromatography of VDE3 sample in two different 
buffers: Tris-HCl (pH 8.0) and citrate phosphate (pH 5.2). To investigate if the VDE 
worked as dimer-form, several experiments had been processed by our group. The 
activity of the purified Cys11 mutant, purified VDE3 and their 1:1 mixture have been 
measured (by using HPLC method). The result showed activity decrease to half when 
purified VDE3 mixed with same amount purified Cys11 mutant compare to sample 
only had purified VDE3 , which support that the VDE3 should work in dimer form. 
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Method 
 
Construction of expression plasmids  
 
For testing the linker region, three groups of peptides have been determined, 
amplified and expressed in following steps. The sequence alignment of 11 plant 
species showed less conserved part in linker region, three break positions have been 
determined based on the result (Figure 4): site QK, site FP and site PS. Corresponding 
to these three sites, six peptides were expressed separately (Figure 5). Peptide L1 
and L2 for site QK, peptide L3 and L4 for site FP, peptide L5 and L6 for site PS. 
 
Figure 4. Sequence alignment result and cleavage sites. The linker region is marked by 
red square and cleavage sites (site QK, FP and PS) are marked by blue lines. On the 
left, the organism list of each sequence from are showed, the spinach are marked by 
cyan box. The conservation, quality and consensus were calculated by Jalview. 
Conservation: conservation of total alignment less than 25% gaps. Quality: Alignment 
quality based on Blosum62 scores. 
 
The full length VDE gene (without signal peptide) has been transferred into pET22b 
plasmid (provided), based on the sequence, the 6 primer pairs of the sequence of 6 
peptides for three break positions were designed (Table 1). The amplification and 
expression of target peptides were processed according to standard molecular 
biology methods. The recombinant plasmid were amplified in E. coli Top10 strain and 
purified, the purified plasmid was sent to eurofins mwg|operon for sequencing to 
assure the sequence correct. The DreamTaq DNA Polymerase, FastDigest Nde1, 
FastDigest BamH1, Shrimp Alkaline Phosphatase, GeneJet PCR purification Kits, 
GeneJet Plasmid MiniPrep Kits, GeneJet Gel Extraction Kits are all from Fermentas. 
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Figure 5. Sequence of constructs peptides. The figure only shows the beginning and 
ending amino acids with position. The expressed proteins are represented by black 
lines. For peptide L2, L4 and L6, the extra Met in N-terminal are not shown. The 
length comparison between the construct peptides and VDE3 was showed in length 
of the lines. The lengths of the lines are not in scale. 
 
In order to test shortest active peptide, three different lengths of peptide were 
determined; these peptides were all deleted a certain length of C-terminal sequence. 
They were: CR1, CR2 and CR3 (Figure 5). The designed primers for these three 
peptides are shown in Table 1, the cloning and expression shared same method as in 
linker test project.  
 
For the Cys function project and the fusion of TEV cleavage test, the mutation was 
processed by using two-step PCR method and Phusion Hot Start II High-Fidelity DNA 
Polymerase (Fermentas). The designed primer pairs for each Cys mutation (Cys1 to 
Cys13) and fusion TEV protease cleavage site were shown in Table 1. The cloning and 
expression of all the mutants shared same method as in linker test project. 
 
TEV protease digestion design 
 
Figure 6 shows the building of a TEV-site fusion VDE. The digestion reaction was 
taken place between Gln (Q) and Glu (E) and processed by using ActTEV® protease 
from invitrogen. Based on the protocol, a series of reaction condition test (see result 
part) finally determined optimal digestion condition and environment: for each 20 μg 
TEV-site fusion VDE, a 150 μl reaction environment within 1 μl ActTEV® protease was 
need; over 90% protein was digested after overnight incubation at 30oC (the bands 
intensity was calculated by using Gel Analyzer).  
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Figure 6. The fusion of TEV protease cleavage site into VDE3. The green color 
sequence in the black color VDE sequence is the linker part. The orange colored 
sequence in VDE3 will be changed into blue colored sequence to make a TEV-site 
fusion VDE. The cleavage site of ACTEV® protease is between Q and G (Marked in 
Black line). 
 
Electrophoresis 
 
The PCR products were identified by 1% Agarose gel electrophoresis. The DNA dye 
used in electrophoresis was Ethidium bromide (added into gel) or DNA-Dye NonTox 
provided by AppliChem (used as loading dye). The running buffer was diluted 50X 
TAE Electrophoresis Buffer from Fermentas. The DNA ladder was GeneRulerTM 1kb 
Plus DNA Ladder from Fermentas.  
 
The protein samples were identified by using sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE). The running buffer was diluted Mops SDS Running 
Buffer (20X) from invitrogen. The precast gel was NuPAGE® Novex® 4-12% Bis-Tris 
Midi Gel from invitrogen. The protein ladder was PageRulerTM Plus Prestained Protein 
Ladder from Fermentas.  
 
Expression of target protein 
 
The correct plasmids were amplified in E.coli Top10 strain, then purified and 
transferred to E.coli BL21 strain for expression. The culture condition of BL21 cells 
was 37oC, 200 rpm. The expression of target protein was induced by 1 mM Isopropyl 
β-D-1-Thiogalactopyranoside (IPTG) when OD600 of cell culture reach 0.6. The 
expression took 2 hours at 37oC and the cells collected by using centrifugation (6000 
RCF, 10 min). The pellet cell was washed (100 mM Tris-HCl, 170 mM NaCl) twice. 
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Cell disruption and purification of expression products 
 
The cell disruption was done by using Lysozyme combined with 0.1 mm cell 
disruption glass beads. The washed cell pellet were resuspended in Lysis buffer (50 
mM Tris-HCl, 10mM Ethylene Diamine Tetraacetic Acid (EDTA), 1% Triton X-100, 500 
mM NaCl, 5mM DL-Dithiothreitol (DTT), pH0.6), the lysozyme amount changes 
according to cell amount (4 mg lysozyme per 1 g cell); after 15 min incubation, same 
volume of glass beads as cell pallet volume were added into the mixture, the 
disruption cycle was: 30 sec vortex and 30 sec on-ice incubation, repeat 15 times.  
 
The homogenates were applied to centrifugation (15 000 RCF, 15 min, 4oC) and 
followed by 5 washing steps to purify the inclusion body, the step1-3 followed same 
cycle: resuspend cell pellet in buffer1 (20 mM Tris-HCl, 10 mM EDTA, 5 mM DTT, 1% 
Triton X-100, pH 8.0), and apply to centrifugation (15 000 RCF, 15 min, 4oC); for step 4, 
cell pellet was resuspended in buffer2 (20 mM Tris-HCl, 10 mM EDTA, 5 mM DTT, pH 
8.0), and applied to centrifugation (15 000 RCF, 15 min, 4oC); for step 5, cell pellet 
was resuspended in buffer3 (20 mM Tris-HCl, 10 mM EDTA, 5 mM DTT, 8 M urea, pH 
8.0), and incubated for 1 hour with magnetic stirrer, then applied to centrifugation 
(15 000 RCF, 30 min, 25oC), the supernatant of step5 was purified solubilized 
inclusion body. 
 
A refolding processed followed the washing steps to reactivate unfolded protein. The 
refolding process was done by using PD-10 Desalting column from GE healthcare, the 
desalting steps followed the protocol of PD-10 column in total 2 cycles, urea and DTT 
was removed one by one in those continues cycles, the component of washing buffer 
in cycle1 was 20 mM Tris-HCl pH8.0, 10 mM EDTA, 5 mM DTT; in cycle2, the buffer 
component was 20 mM Tris-HCl pH8.0, 10 mM EDTA. While desalted protein sample 
eluted from column in the last cycle, the protein sample was mixed with 2 mM 
oxidized Glutatione (GSSG) and 0.3 mM reduced Glutatione (GSH) and incubated 
overnight to allow protein oxidation in redox buffer. The refolded protein was applied 
to gel-filtration chromatography to isolate the active component from missfolded 
and aggregates. The collection from gel-filtration chromatography was applied to 
concentrating steps (by using Vivaspin 15R tubes from Sartorius stedim biotech) to 
get a high concentration protein sample. 
 
 
Activity assay 
 
Activity measurements were based on dual-wavelength measurements (A502-A540) 
according to Yamamoto and Higashi (1978). The measurements were processed on 
UV-3000 spectrophotometer. The measurement condition was citrate buffer (50 mM 
citric acid, 110 mM Na2HPO4, pH 5.2), the substrate was 0.33 μM Violaxanthin and 9 
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μM Monogalactosyldiacylglycerol (MGDG), 30 mM Ascorbate was added after VDE 
incubated with substrate in buffer for 3 min to start the reaction. 
 
Activity measurement by using HPLC 
 
For some low activity protein sample, the dual-wavelength method could not detect 
its activity; a new method was applied to detect how much violaxanthin can be 
converted to zexanthin by certain protein sample. The conversion was measured by 
using High Performance Liquid Chromatography (HPLC) with C18 HPLC column from 
Agilent Technologies. The preparation of loading sample was as follows: a 200 μl 
reaction system was set up, with 20 μl Violaxanthin and MGDG mixture (66 μM 
Violaxanthin and 1.8 μM MGDG), 20 μl protein sample, 6 μl 1 mM Ascobate and 154 
μl H2O; after 1 hour incubation, the reaction was stopped by using 3.5 μl NaOH, 800 
μl Acetone was added to the reaction solution to extract pigments and centrifuge at 
13 200 RCF for 10 min to pellet down insoluble component; in order to make sure no 
insoluble particle will load into column, a repeat centrifugation will applied to the 
previous supernatant. To increase to polarity, 150 μl H2O was added into Acetone 
solution before loading. For linker sample (L1 to L6), due to their low activity, the 
measurement was done by use non-diluted sample; as for measurement of VDE and 
Cys11 mixture (for dimerization research), the VDE was diluted 12 000 times to lower 
the reaction speed into an 1 hour time scale, the Cys11 sample was diluted to the 
same concentration as VDE.  
 
Gel-filtration chromatogram 
 
The analytical and purification-purpose gel-filtration chromatography column were 
packed with Sephacryl S-200 material (from GE healthcare). The packing steps of 
analytical column were followed protocol provided by GE healthcare. For larger scale 
purification of expression products, a HPLC system was connected with a prepacked 
Sephacryl S-200 column (from GE healthcare).  
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Table 1. Sequence of primer pairs for peptides constructs. 
 
Primer pair 1 (5'---->3') Primer pair 2 (5'---->3')
Cleavage
site QK
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: GCCGGATCCTTACTGAGGCACGCATTTC
Sense primer: CGTCATATGAAGTCTGATGTTGGAGAATTTC
Anti-sense primer: TTCGGATCCTTACCGAAG
Cleavage
site FP
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: GCCGGATCCTTAAAATTCTCCAACATCAGAC
Sense primer: CGTCATATGCCTGTTCCCGATCCTAGTG
Anti-sense primer: TTCGGATCCTTACCGAAG
Cleavage
site PS
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer:GCCGGATCCTTAAGGATCGGGAACAGGA
Sense primer:  CGTCATATGAGTGTGCTCGTTAAGAGTTTC
Anti-sense primer: TTCGGATCCTTACCGAAG
Primer pair (5'---->3')
Peptide
M1 to
G250
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: GTCGGATCCTTACCCACAGGTATTGTCCG
Peptide
M1 to
G266
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: GTCGGATCCTTATCCTTCCTCCACCGTC
Peptide
M1 to
E278
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: GTCGGATCCTTATTCTAATTGTTCTACTTCCTTAA
1st step PCR primer pair (5'---->3') 2nd step PCR primer pair (5'---->3')
Cys08Ser
(Cys1)
Sense primer1: GATGCTCTTAAAACTTCTACCTGTTTGCTGAAGG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CCTTCAGCAAACAGGTAGAAGTTTTAAGAGCATC
Cys10Ser
(Cys2)
Sense primer1: CTCTTAAAACTTGTACCTCTTTGCTGAAGGAATGC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GCATTCCTTCAGCAAAGAGGTACAAGTTTTAAGAG
Cys15Ser
(Cys3)
Sense primer1: GTTTGCTGAAGGAATCCAGAATTGAACTCGC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GCGAGTTCAATTCTGGATTCCTTCAGCAAAC
Cys22Ser
(Cys4)
Sense primer1: GAACTCGCCAAGTCCATCGCAAATCC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GGATTTGCGATGGACTTGGCGAGTTC
Cys28Ser
(Cys5)
Sense primer1: TCGCAAATCCATCTTCTGCAGCCAATGTTG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CAACATTGGCTGCAGAAGATGGATTTGCGA
Cys34Ser
(Cys6)
Sense primer1: GCCAATGTTGCTTCCCTGCAGACCTGC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GCAGGTCTGCAGGGAAGCAACATTGGC
Cys38Ser
(Cys7)
Sense primer1: CTTGCCTGCAGACCTCCAATAATAGACCTG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CAGGTCTATTATTGGAGGTCTGCAGGCAAG
Cys47Ser
(Cys8)
Sense primer1: CTGATGAAACCGAATCCCAAATCAAATGTG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CACATTTGATTTGGGATTCGGTTTCATCAG
Cys51Ser
(Cys9)
Sense primer1: GAATGCCAAATCAAATCTGGGGACTTGTTC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GAACAAGTCCCCAGATTTGATTTGGCATTC
Cys66Ser
(Cys10)
Sense primer1: GACGAGTTCAACGAGTCTGCAGTCTCTCG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CGAGAGACTGCAGACTCGTTGAACTCGTC
Cys73Ser
(Cys11)
Sense primer1: CTCGAAAGAAATCCGTGCCTCAGAAGTCTG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CAGACTTCTGAGGCACGGATTTCTTTCGAG
Cys119Ser
(Cys12)
Sense primer1: GACGCTTTTGATTCCCAGTTACATGAGTTCC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GGAACTCATGTAACTGGGAATCAAAAGCGTC
Cys249Ser
(Cys13)
Sense primer1: CGAACGGACAATACCTCTGGGCCCGAG
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: CTCGGGCCCAGAGGTATTGTCCGTTCG
1st step PCR primer pair (5'---->3') 2nd step PCR primer pair (5'---->3')
Sense primer1: CTGGAAGTACAGGTTCTCAGGCACGCATTTCTTTC
Anti-sense primer1: TTCGGATCCTTACCGAAG
Sense primer2: TTAAGAAGGAGATATACATATGG
Anti-sense primer2: GAGAACCTGTACTTCCAGGGAGAATTTCCTGTTCCC
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: TTCGGATCCTTACCGAAG
Linker test
project
Cys mutation
test
Sense primer: TTAAGAAGGAGATATACATATGG
Anti-sense primer: TTCGGATCCTTACCGAAG
Fusion of TEV protease
cleavage site
C-terminal
deletion test
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Result 
 
Cysteine contributes to VDE activity to different extent 
 
The sequencing results showed the DNA sequence in reconstructed plasmid matches 
to the designed sequence. After purification of protein samples, all samples 
(including mutant from 1st Cys to 13th Cys (sample number Cys1 to Cys13) and VDE3 
(F1, F2 and F3)) were applied to SDS-PAGE and checked for the product size, the 
SDS-PAGE result are shown in Figure 7. The size of mutants and VDE3 are same, at 
around 40 kDa, and the bands position on the gel matched to the molecular weight. 
 
Figure 7. SDS-PAGE result of Cysteine mutant products. The size of ladders is shown in 
both sides. The sample name is marked in each lane, from left to right, top to bottom, 
were 13 mutants (sample number Cys1 to Cys13) and 3 VDE3 samples (from different 
batch), from sequence data, all mutants and VDE3 share same molecular mass at 
around 40 kDa. The shallow band at around 100kDa in each line is suspected VDE 
dimer bands. 
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The activity measurement results from dual-wavelength method are given below 
(Figure 8). Based on activity and protein concentration, specific activity of each 
mutants and VDE3 were calculated and listed in one figure. The result of activity 
measurements was calculated from average of three parallel measurements. The 
average specific activity of 3 VDE3 was set as standard (100% activity), based on 
standard activity, the percentage number of each mutant were calculated. The 
results showed except the mutant which the 1st Cys mutate to Ser (Cys1), all other 
mutants gave very low activity compare to VDE3. Cys1 showed much higher activity 
than wild type (1.5 times), for other mutants, their activity were deeply affected by 
Cys mutation to Ser, the most active mutant Cys8 only showed 3.5% of the wild type 
activity, and some mutants even showed less than 0.001% of wild type activity. 
 
Figure 8. Relative activities of Cysteine mutants. The activity of each mutants was 
compared with VDE3 (F) and presented in a percentage number (relative activity) A. 
the overview of all mutants (Cys1 to Cys13) and average of VDE3. B. the relative 
activity of 12 low-active mutants. 
 
Linker region contributes to VDE activity 
 
In order to identify how the 6 peptide of linker project expressed in E. coli cell, the 
supernatant and pellet of the 1st centrifugation after cell disruption of each sample 
were applied to SDS-PAGE. The result (Figure 9) showed 3 larger size peptides (L2, L4 
and L6) formed inclusion body during expression and showed three clear bands in 
those pellet lanes. As for the three small size peptide, they showed different 
expression condition, L1 was found in inclusion bodies, L3 was found in both soluble 
protein and inclusion bodies, while the L5 was only found in the soluble protein 
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fraction. Since the mass of each small peptide is less than 10 kDa, their bands 
position were not match to ladder, while their relative movement position in gel 
were still according to their mass difference, and could be visualized in the gel 
(marked by black arrow).  
 
Figure 9. SDS-PAGE result of identification of arrangement of six peptide expression in 
E.coli. Six samples were loaded in order by number and supernatant (S) before pellet 
(P). The size of each sample: L1, 8.2 kDa; L2, 31.4 kDa; L3, 8.9 kDa; L4, 30.7 kDa; L5, 
9.5 kDa; L6, 30.2 kDa. 
 
The activity measurement result by using dual-wavelength method of the six peptide 
combination showed no activity. Another measurement by using HPLC detecting 
pigments conversion was applied to three combinations: L1+L2, L3+L4, L5+L6. The 
result was shown in Table 2. It can be seen that after 1 hour incubation, combination 
L1+L2 gave no conversion from Vx to Ax or Zx; combination L3+L4 converted less that 
1% Vx into Ax but no conversion to Zx; and the combination L5+L6 converted more 
than 7% of Vx to Ax and 1.31% Vx finally converted to Zx. The background test of 6 
independent peptides showed no conversion detected.  
 
Table 2. Result of HPLC detecting different pigment amount in different sample 
combination. The area is calculated by the integration of peaks from the HPLC 
chromatogram. 
 
 
Combination Vx Ax Zx
L1 and L2 100.00 0.00 0.00
L3 and L4 99.63 0.37 0.00
L5 and L6 92.73 5.96 1.31
 Relative Amount (%)
15 
 
TEV site fusion VDE shows low activity 
 
Figure 10A shows the result of digestion condition test. The calculation result from 
Gel Analyzer showed in lane 30oC, over 90% of VDE was digested into two peptides 
after overnight incubation at 30oC. The activity measurement result showed 
expressed TEV-site fusion VDE has very low activity (1/1000 of VDE3), and no activity 
was found for the digestion products. Due to the fact that 30 μM DTT in ACTEV 
protease restoration buffer which was enough to inhibit 130 μg/ml VDE3, 100 μM 
GSSG was mixed with ACTEV protease before cleavage reaction to create an oxidative 
state and remove the influence of DTT. While the digestion result in Figure 10B, 
showed overnight incubation at 30oC still gave almost no digestion products, the 
ACTEV protease was highly inhibited.  
 
 
Figure 10. SDS-PAGE result of ACTEV protease digestion condition test. A. Digestion 
test of different incubation temperature. B. Digestion test in oxidative state. The 
size of different peptides in reaction solution: TEV-site fusion VDE, 40 kDa; ACTEV 
protease, 27 kDA; large size digestion product, 31 kDa; small size digestion product, 
8.8 kDa. The band at 100 kDa position in each line is suspected dimer of fusion VDE. 
The band between 35 kDa and 25 kDa is ACTEV protease. 
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C-terminal length influences VDE activity 
 
Figure 11 showed the SDS-PAGE of purified soluble inclusion body of expression 
product in C-terminal function project. By comparing with protein ladder, the bands 
position of 3 products matched to their expected molecular size.  
 
Figure 11. SDS-PAGE gel of CR1, CR2, CR3 and VDE3. For each sample, 2 different 
concentrations were loaded: origin dialysis products (1X) and 10 times dilution 
(10X). The mass of each sample: VDE3, 40 kDa; CR1, 28 kDa; CR2, 30 kDa; CR3, 31 
kDa. The dimer bands can also be seen in lanes 1X of each protein sample. 
 
The activity measurement result was shown in Figure 12. The result showed CR3 
remained 20% of VDE3 activity, while the activity of CR2 and CR1 were considerably 
lower (2.1% and 0.19% of full activity remained). 
 
 
Figure 12. Relative activity of 3 different-length-C-terminal-removed peptides (CR1, 
CR2 and CR3) compared to VDE3 (F). A. Overview of relative activity from all 
samples. B. Relative activity of CR2 and CR1. 
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Dimerization of VDE3 
 
Figure 13 shows the comparison of two different chromatograms in the same 
analytical Sephacryl S-200 column. The blue chromatogram was from 260 μg VDE 
loaded in pH 8.0 Tris-HCl environment; the red chromatogram was from same 
amount VDE3 loaded into pH 5.2 citrate phosphate buffer after incubated 30 min in 
the same buffer. It can be seen that a 2 ml peak shift appeared, which means the size 
of VDE in low pH buffer were different from in high pH buffer; which can be 
explained by a dimerization of VDE3 in acidic condition.  
 
Figure 13. Chromatogram of VDE in low pH (pH 5.2) and high pH (pH 8.0). The flow 
speed was 0.3 ml/min. The Elution volumes of two peaks were: 18 ml (VDE in pH 
5.2) and 20ml (VDE in pH 8.0) 
 
Figure 14 A B C shows the activity measurement result of VDE3, Cys11 and their 
mixture by using HPLC method. The result was given by the trend of three 
components changed in certain time scale (1 hour). The result showed in both VDE3 
sample and VDE3+Cys11 mixture, the amount of Vx decreased and Zx increased 
following time changing. The Cys11 sample had no component changing and no Ax 
or Zx was converted. The Figure 14D was the merger of two diagrams: VDE diagram 
and VDE+Cys11 mixture diagram, for convenient to see component changes in Vx 
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and Zx, curve of Ax were not shown. It can be seen in Figure 14D that the slope of 
curves in VDE diagram are higher than that in VDE+Cys11 mixture diagram. 
 
Figure 14E is the merger of two diagram: VDE3 diagram was in 1 hour time scale; as 
for the diagram of mixture, the speed of reaction was artificially doubled by 
compressing the 4 measurements (7th min, 15th min, 30th min and 60th min) from 1 
hour time scale into 30 minutes time scale but with same number of measurements 
(3.5th min, 7.5th min, 15th min and 30th min). The new made diagram of VDE3+Cys11 
mixture showed almost same trend as the VDE diagram. 
 
Figure 14. The diagram of activity measurement of VDE, Cys11, and their mixture 
by using HPLC method. All components (Vx, Ax and Zx) are shown in percentage of 
total amount (total integration value of peak area). Figure A, B and C are 
correlated to sample VDE, Cys11 and their mixture separately. Figure D is the 
merger of A and C without Ax curves. Figure E is merger of A and artificially 
modified C. 
 
Figure 15 showed the comparison of two different chromatograms in the same 
purification Sephacryl S-200 column at pH 8.0 Tris-HCl buffer. The blue diagram was 
from refolded VDE3 inclusion body; the red diagram was from refolded 
C-terminal-cleaved VDE (sample CR1) inclusion body. In each chromatogram, three 
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main peaks can be seen. They were, in size order, aggregation peak, dimer peak and 
monomer peak. The activity of each peak showed only the monomer peak in VDE 
sample and dimer peak in CR1 sample were active.  
 
 
 
Figure 15. The chromatogram of refolded CR1 and VDE inclusion body in pH 8.0 
buffer. The elution volume of CR1 dimer and VDE monomer were 148 ml and 156 
ml. The size of CR1 and VDE monomer were 28 kDa and 40 kDa. The diagram 
before 70 ml was not shown. The starting point was used to mark diagram 
direction. The flow speed was 1ml/min 
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Discussion 
 
The activity measurement result of different Cys mutants showed that all Cys except 
the first Cys were important for VDE activity. For those mutants that showed low 
activity, the data was from dual-wave length method, and the reading from UV-3000 
spectrophotometer was close to the detection limit; thus we cannot assure if the low 
activity read mutants truly active. 
 
Cys1 is the only mutant that shows higher activity than VDE3. Sequence alignment 
showed that Cys1 was less conserved in VDE than other Cys, e.g., Cys1 was not 
present in some algae species. This suggests that the Cys1 is a free Cys and has less 
contribution to VDE activity and structure. Another possible suggestion of Cys1 
function is that it might form a disulfide bond with the Cys in signal peptide during 
expression. But the reason of mutant Cys1 highly increased activity still needs further 
research.  
 
The two least active Cys mutants, Cys12 and Cys13 are located in lipocalin domain. 
From the structure of lipocalin domain obtained by Arnoux’s group (Arnoux et al, 
2009), the two Cys are close in spatial position, illustrated that they might form a 
disulfide bond to maintain the pocket structure stable. From Cys2 to Cys11, they all 
are located in the N-terminal domain, and any of them mutated to Ser caused loss of 
almost all activity.  
 
It should be noticed that the only difference between Cys and Ser is that the –SH 
group change to a –OH group; and the ability of form a disulfide bridges disappeared. 
Such phenomenon may lead to a conclusion that the accumulation of Cys In 
N-terminal domain was mainly to form a special stable structure. Such structure 
might require all Cys (except Cys1) in N-terminal domain, because ideally, 10 Cys 
could form 5 disulfide bonds and no free Cys left; and 5 disulfide bonds were enough 
to keep a stable structure. Due to Cys7 and Cys8 showed higher activity than other 8 
Cys mutants, these two Cys (Cys38 and Cys47) might contribute to less important 
disulfide bond formation than other 8 Cys.  
 
On the other hand, due to the fact that vitamin K epoxide reductase use two Cys in 
the active site (R.B.Silverman, 1981), it is tempting to suggest that cysteines in VDE is 
involved in catalysis. Because of the location of the active site of VDE is still unknown, 
investigation about whether the Cys in N-terminal contribute in catalitical way or 
structural way needs further work. 
 
In 1998, Niyogi et al successfully isolated a natural Arabidopsis thaliana mutant that 
could not tolerate rapid light change. The mutant was named npq1-1. The mutation 
happened in npq1-1 is the last Cys in Cys-rich domain (same position as in sample 
Cys11) mutates to Tyr. The mutant lost fully activity. We mutate the Cys at the same 
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place to Ser but in the different species (spinach), the result showed 0.1% of VDE3 
activity was left. Compare with Tyr, the shape and property of Ser are much closer to 
Cys, the activity of mutants still decrease dramatically. Our result matches to the 
discovery from Niyogi’s group. 
 
In the linker function test, the activity of the 3 combinations were measured by the 
HPLC method due to the dual-wavelength method was insufficient to measure this 
low activity. This illustrate that the 6 peptides might not form correct folding 
independently or the collision between two domains into correct position required 
more time during the conversion reaction. It should be mentioned that in the 
beginning of activity assay by using HPLC method, the reaction was taken place in 
citrate-phosphate buffer, and we got very low amount of Vx conversion to Ax and Zx. 
After changing the citrate buffer to MES buffer at same pH by lower ion strength, the 
conversion of Vx to Ax and Zx was higher. This illustrate the salt in the activity assay 
buffer can influence the interaction between the two domains.  
 
From the Figure 9, it should be noticed that the three small size peptides (L1, L3 and 
L5) showed different solubility. L1 is found in pellet, L3 can be found in both pellet 
and supernatant, L5 can only be found in supernatant. And from the result of activity 
assay, L5+L6 group showed higher activity than L3+L4 group while L1+L2 group gives 
no activity. We suggest that the three small size peptides have different ability to fold 
correctly and independently, or they have different solubility. And due to the dialysis 
method is lower efficient than the desalting column, it cannot completely remove 
urea. The refolding of L1 and L3 might not as complete as L5. And the L5 exist in 
soluble form after expression, it might remain more activity. 
 
On the other hand, in the linker region (VPQKSDVGEFPVPDPSVLV), L1 and L2 were 
separated at position between Gln and Lys (QK), while the TEV-site was fused 
between position QK and FP; the low activity of the TEV-site fusion VDE and 
non-active peptide combination L1+L2 showed the real linker region should be 
smaller than what we suggested from the sequence alignment result (Figure 5). The 
sequence VPQKSDVGEF could have more functions than connecting the N-terminal 
and lipocalin domain. The successful cleavage of TEV-site fusion VDE showed that the 
linker region should be located in the surface of protein in VDE because the ACTEV 
protease cannot find and cleave the recognition sequence buried in protein. This also 
proved by the hydrophobicity plot by using ProtScale (Kyte & Doolittle scale, window 
size 3) prediction result. Such illustrated the linker region might be a loop structure 
with stable structure that can keep two domains connected and maintained in a 
certain angle.  
 
The TEV-site fusion VDE was designed to detect if the two domains before and after 
the linker region were necessary to each other while folding. But the DTT in reaction 
buffer fully inhibited the VDE activity. The oxidative environment created by GSSG 
can fully remove the reducing power of DTT, but the step of mixed GSSG with 
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protease solution before the reaction highly reduced the activity of the protease; and 
on the other hand, the GSSG cannot remove the influence of DTT if GSSG was added 
after cleavage reaction. In conclusion, the solution to reduce the influence of DTT 
and at the same time keep the ACTEV protease active is to allow the protease cleave 
the TEV-site fusion protein and remove the DTT. 
 
The activity measurement of the C-terminal-cleaved VDE3 showed that the truncated 
VDE3 lost activity. The longer distance C-terminal is removed, the less activity left. 
The truncated VDE3 with the whole C-terminal sequence removed (sample CR1) 
showed only about 0.2% of VDE3 activity. This result illustrated that besides the 
membrane binding function, which was suggested by Bugos and Yamamoto, the 
C-terminal might also influence the conversion of Vx to Ax and Zx or substrate 
binding function. Even though CR1 has low activity, it showed that the VDE3 without 
C-terminal was still able to convert from Vx to Ax and Zx. Therefore it would still be 
interesting to obtain the structure of CR1. 
 
The research from A.D. Hieber et al (2001) showed that the truncated VDE from 
Arabidopsis thaliana with 278 amino acids (same size as CR3) shows full activity, and 
the 257 amino acid-length-VDE (7 amino acids more than CR1) showed no activity at 
all. But our experiment result showed some difference. Sample CR1 still shows a low 
activity while CR3 showed only 20% of full activity. The reason of such phenomenon 
might be our purification method is with higher efficiency than method in Hieber’s 
group and spinach VDE is different from Arabidopsis thaliana VDE. The purification 
steps by using gel-filtration chromatography and desalting column produced high 
purity protein sample. The activity comparison of other sample to the high purity 
VDE3 is more accurate.  
 
On the other hand, from Figure 15, it can be seen that the active oligomeric state of 
CR1 and VDE3 are different in high pH. CR1 can form active dimer in high pH, and 
was suggested that it might relate to the removal of 99 amino acid-C-terminal 
peptide. The C-terminal might influence the VDE3 molecule contacts to each other to 
form dimer at high pH. Due to our following discovery, the VDE3 forms dimer in low 
pH (Figure 13). Together with research of Bugos and Yamamoto in 1996, this process 
might be explained by that the low pH caused structural change of the C-terminal 
domain and induced its membrane binding function, and without the disturbance of 
C-terminal, other part of VDE formed dimer for conversion of Vx. 
 
Figure 13 suggests the formation of VDE3 dimers at low pH. However, the 2 ml peak 
shift is not a reliable support of dimerization of VDE3 in low pH, besides the hight of 
VDE3 peak in low pH is only about 20% of that in the high pH which means around 80% 
of VDE3 sample were changed into insoluble form.  
 
Another experiment was set up to reduce the reaction speed into a long time period 
and measure the conversion from Vx to Ax until Zx by using HPLC method. From our 
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prediction that the dimerization of VDE3 monomer would happen when the 
environment pH decreases to acidic state, if active VDE3 and non-active Cys11 were 
mixed together, the chance of VDE3 monomer form dimer with another VDE3 
monomer decreased to half. The Figure 14E provided the evidence that support the 
dimerization of active VDE3: the diagram of the artificial doubled speed VDE3+Cys11 
matched to the diagram of Figure 14A. The merged diagram showed the conversion 
speed of VDE+Cys11 is just the half of speed of VDE3. 
 
In Figure 15, it can be seen that the peak of active CR1 sample appeared earlier than 
active VDE3 sample. The comparison of the position of the three peaks in each 
diagram shows CR1 should work in dimer form. The dimerization of CR1 even 
happened in high pH and the activity assay showed the monomer peak in CR1 
diagram is inactive. Such phenomenon illustrated that VDE can dimerization at high 
pH without C-terminal region. In another word, C-terminal might influence the VDE 
activity in some other ways, but what we can confirm is it does influence the 
dimerization of VDE. But the domain that mainly contributed to the dimerization of 
VDE remains unknown. 
 
In future work, a Circular Dichroism spectrum (CD spectrum) is suggested to analyze 
the folding of each Cys mutants to identify the Cys which contribute to VDE structure 
stability. Large scale TEV-protease digestion should be set up to prepare enough 
digestion products to load on PD-10 desalting column to remove DTT in the solution; 
the two active peptides will be loaded in low pH native gel electrophoresis to identify 
domain that contribute to dimer formation. The active short peptide L3 and would 
also be subjected to Nuclear Magnetic Resonance (NMR) method to obtain structure; 
at the same time, crystallization condition screens of CR1, CR2 and CR3 would be set 
up and further, obtain the structure. 
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